SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Carlsson J) ;mspu:(researchreview)"

Sökning: WFRF:(Carlsson J) > Forskningsöversikt

  • Resultat 1-10 av 14
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Carlsson, Arvid, 1923, et al. (författare)
  • Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence
  • 2001
  • Ingår i: Annu Rev Pharmacol Toxicol. - 0362-1642. ; 41, s. 237-60
  • Forskningsöversikt (refereegranskat)abstract
    • In spite of its proven heuristic value, the dopamine hypothesis of schizophrenia is now yielding to a multifactorial view, in which the other monoamines as well as glutamate and GABA are included, with a focus on neurotransmitter interactions in complex neurocircuits. The primary lesion(s) in schizophrenia does not necessarily involve any of these neurotransmitters directly but could deal with a more general defect, such as a faulty connectivity of developmental origin. Nevertheless, a precise identification of neurotransmitter aberrations in schizophrenia will probably provide clues for a better understanding of the disease and for the development of new treatment and prevention strategies.
  •  
3.
  • de Waard, Anne-Karien M., et al. (författare)
  • Barriers and facilitators to participation in a health check for cardiometabolic diseases in primary care : A systematic review
  • 2018
  • Ingår i: European Journal of Preventive Cardiology. - : SAGE PUBLICATIONS LTD. - 2047-4873 .- 2047-4881. ; 25:12, s. 1326-1340
  • Forskningsöversikt (refereegranskat)abstract
    • Background: Health checks for cardiometabolic diseases could play a role in the identification of persons at high risk for disease. To improve the uptake of these health checks in primary care, we need to know what barriers and facilitators determine participation.Methods: We used an iterative search strategy consisting of three steps: (a) identification of key-articles; (b) systematic literature search in PubMed, Medline and Embase based on keywords; (c) screening of titles and abstracts and subsequently full-text screening. We summarised the results into four categories: characteristics, attitudes, practical reasons and healthcare provider-related factors.Results: Thirty-nine studies were included. Attitudes such as wanting to know of cardiometabolic disease risk, feeling responsible for, and concerns about one's own health were facilitators for participation. Younger age, smoking, low education and attitudes such as not wanting to be, or being, worried about the outcome, low perceived severity or susceptibility, and negative attitude towards health checks or prevention in general were barriers. Furthermore, practical issues such as information and the ease of access to appointments could influence participation.Conclusion: Barriers and facilitators to participation in health checks for cardiometabolic diseases were heterogeneous. Hence, it is not possible to develop a one size fits all' approach to maximise the uptake. For optimal implementation we suggest a multifactorial approach adapted to the national context with special attention to people who might be more difficult to reach. Increasing the uptake of health checks could contribute to identifying the people at risk to be able to start preventive interventions.
  •  
4.
  • Gotfredsen, Klaus, et al. (författare)
  • Implants and/or teeth: consensus statements and recommendations.
  • 2008
  • Ingår i: Journal of oral rehabilitation. - : Wiley. - 1365-2842 .- 0305-182X. ; 35:Suppl 1, s. 2-8
  • Forskningsöversikt (refereegranskat)abstract
    • In August 23-25, 2007, the Scandinavian Society for Prosthetic Dentistry in collaboration with the Danish Society of Oral Implantology arranged a consensus conference on the topic 'Implants and/or teeth'. It was preceded by a workshop in which eight focused questions were raised and answered in eight review articles using a systematic approach. Twenty-eight academicians and clinicians discussed the eight review papers with the purpose to reach consensus on questions relevant for the topic. At the conference the consensus statements were presented as well as lectures based on the review articles. In this article the methods used at the consensus workshop are briefly described followed by the statements with comments.
  •  
5.
  • Ballante, Flavio, et al. (författare)
  • Structure-Based Virtual Screening for Ligands of G Protein-Coupled Receptors : What Can Molecular Docking Do for You?
  • 2021
  • Ingår i: Pharmacological Reviews. - : AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS. - 0031-6997 .- 1521-0081. ; 73:4, s. 527-565
  • Forskningsöversikt (refereegranskat)abstract
    • G protein-coupled receptors (GPCRs) constitute the largest family of membrane proteins in the human genome and are important therapeutic targets. During the last decade, the number of atomic -resolution structures of GPCRs has increased rapidly, providing insights into drug binding at the molecular level. These breakthroughs have created excitement regarding the potential of using structural information in ligand design and initiated a new era of rational drug discovery for GPCRs. The molecular docking method is now widely applied to model the threedimensional structures of GPCR-ligand complexes and screen for chemical probes in large compound libraries. In this review article, we first summarize the current structural coverage of the GPCR superfamily and the understanding of receptor-ligand interactions at atomic resolution. We then present the general workflow of structure-based virtual screening and strategies to discover GPCR ligands in chemical libraries. We assess the state of the art of this research field by summarizing prospective applications of virtual screening based on experimental structures. Strategies to identify compounds with specific efficacy and selectivity profiles are discussed, illustrating the opportunities and limitations of the molecular docking method. Our overview shows that structure-based virtual screening can discover novel leads and will be essential in pursuing the next generation of GPCR drugs. Significance Statement--Extraordinary advances in the structural biology of G protein-coupled receptors have revealed the molecular details of ligand recognition by this large family of therapeutic targets, providing novel avenues for rational drug design. Structure-based docking is an efficient computational approach to identify novel chemical probes from large compound libraries, which has the potential to accelerate the development of drug candidates.
  •  
6.
  • Carlsson, J, et al. (författare)
  • Tumour therapy with radionuclides: assessment of progress and problems
  • 2003
  • Ingår i: Radiotherapy and Oncology. - 1879-0887. ; 66:2, s. 107-111
  • Forskningsöversikt (refereegranskat)abstract
    • Radionuclide therapy is a promising modality for treatment of tumours of haematopoietic origin while the success for treatment of solid tumours so far has been limited. The authors consider radionuclide therapy mainly as a method to eradicate disseminated tumour cells and small metastases while bulky tumours and large metastases have to be treated surgically or by external radiation therapy. The promising therapeutic results for haematological tumours give hope that radionuclide therapy will have a breakthrough also for treatment of disseminated cells from solid tumours. New knowledge related to this is continuously emerging since new molecular target structures are being characterised and the knowledge on pharmacokinetics and cellular processing of different types of targeting agents increases. There is also improved understanding of the factors of importance for the choice of appropriate radionuclides with respect to their decay properties and the therapeutic applications. Furthermore, new methods to modify the uptake of radionuclides in tumour cells and normal tissues are emerging. However, we still need improvements regarding dosimetry and treatment planning as well as an increased knowledge about the tolerance doses for normal tissues and the radiobiological effects on tumour cells. This is especially important in targeted radionuclide therapy where the dose rates often are lower than 1 Gy/h. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
  •  
7.
  • Carlsson, Sigrid, 1982, et al. (författare)
  • What's new in screening in 2015?
  • 2016
  • Ingår i: Current Opinion in Urology. - : Ovid Technologies (Wolters Kluwer Health). - 0963-0643. ; 26:5, s. 447-458
  • Forskningsöversikt (refereegranskat)abstract
    • Purpose of review The aim of this review was to highlight important articles in the field of prostate cancer screening published during 2015 and early 2016. Four major areas were identified for the purpose: screening strategies, post-United States Preventive Services Task Force (USPSTF) 2011-2012, screening trends/patterns, and shared decision making. Several studies furthered the evidence that screening reduces the risk of metastasis and death from prostate cancer. Multiplex screening strategies are of proven benefit; genetics and MRI need further evaluation. Prostate-specific antigen (PSA) screening rates declined in men above age of 50 years, as did the overall prostate cancer incidence following the USPSTF 2011-2012 recommendation against PSA. The consequences of declining screening rates will become apparent in the next few years. More research is needed to identify the most optimal approach to engage in, and implement, an effective shared decision-making in clinical practice. Data emerging in 2015 provided evidence on the question of how best to screen and brought more steps in the right direction of 'next-generation prostate cancer screening'. Screening is an ongoing process in all men regardless of whether or not they might benefit from early detection and treatment. After the USPSTF 2011-2012 recommendation, the rates of PSA testing are declining; however, this decline is observed in all men and not solely in those who will not benefit from the screening. The long-term effect of this recommendation might not be as anticipated. More studies are needed on how to implement the best available evidence on who, and when, to screen in clinical practice.
  •  
8.
  • Carlsson, Torkel, et al. (författare)
  • Early environmental risk factors for neurodevelopmental disorders - a systematic review of twin and sibling studies
  • 2021
  • Ingår i: Development and psychopathology (Print). - : Cambridge University Press. - 0954-5794 .- 1469-2198. ; 33:4, s. 1448-1495
  • Forskningsöversikt (refereegranskat)abstract
    • While neurodevelopmental disorders (NDDs) are highly heritable, several environmental risk factors have also been suggested. However, the role of familial confounding is unclear. To shed more light on this, we reviewed the evidence from twin and sibling studies. A systematic review was performed on case control and cohort studies including a twin or sibling within-pair comparison of neurodevelopmental outcomes, with environmental exposures until the sixth birthday. From 7,315 screened abstracts, 140 eligible articles were identified. After adjustment for familial confounding advanced paternal age, low birth weight, birth defects, and perinatal hypoxia and respiratory stress were associated with autism spectrum disorder (ASD), and low birth weight, gestational age and family income were associated with attention-deficit/hyperactivity disorder (ADHD), categorically and dimensionally. Several previously suspected factors, including pregnancy-related factors, were deemed due to familial confounding. Most studies were conducted in North America and Scandinavia, pointing to a global research bias. Moreover, most studies focused on ASD and ADHD. This genetically informed review showed evidence for a range of environmental factors of potential casual significance in NDDs, but also points to a critical need of more genetically informed studies of good quality in the quest of the environmental causes of NDDs.
  •  
9.
  • Goeijenbier, M., et al. (författare)
  • Seoul hantavirus in brown rats in the Netherlands : implications for physicians Epidemiology, clinical aspects, treatment and diagnostics
  • 2015
  • Ingår i: Netherlands Journal of Medicine. - 0300-2977 .- 1872-9061. ; 73:4, s. 155-160
  • Forskningsöversikt (refereegranskat)abstract
    • The recent discovery of Seoul hantavirus (SEOV) presence in wild rat populations in the Netherlands has direct implications for Dutch clinicians and hantavirus diagnostics. SEOV is amongst the Old World hantaviruses which cause haemorrhagic fever and renal syndrome (HFRS) in humans. HFRS is characterised by a classical triad of fever, acute kidney injury and haemorrhage, but can show different signs and symptoms in specific cases. SEOV is transmitted from infected rats to humans by inhalation of aerosolised excreta. When compared with the known circulating hantaviruses in the Netherlands, Puumala (PUUV) and Tula (TULV), SEOV causes a more severe form of HFRS. Data from cohort studies undertaken in China and Northern Europe show differences in signs and symptoms at onset of disease, (haemorrhagic) complications and mortality. Furthermore, routine diagnostics currently available for hantavirus diagnosis in the Netherlands are not optimised for SEOV detection. The clinical outcome of an SEOV and PUUV infection will greatly benefit from an early diagnosis which will reduce the costs of unnecessary tests and treatments as well. The discovery of SEOV circulation in the Netherlands follows recent findings of SEOV infections in both rodents and humans in England, Wales, France, Belgium and Sweden, indicating the emerging character of SEOV and a high importance of this hantavirus for Public Health in large areas of Europe. Here, we review the current knowledge on the clinical manifestation of SEOV versus PUUV infections in humans, the treatment of clinical cases and diagnostics.
  •  
10.
  • Lehmann, Ordan J, et al. (författare)
  • Fox's in development and disease.
  • 2003
  • Ingår i: Trends in genetics : TIG. - 0168-9525. ; 19:6, s. 339-44
  • Forskningsöversikt (refereegranskat)abstract
    • Since the first forkhead (Fox) gene was identified, the importance of this family of transcription factors has increased steadily with the discoveries of the diverse range of developmental processes that they regulate in eukaryotes. Among other processes, the Fox factors are important in the establishment of the body axis and the development of tissues from all three germ layers. In this article, we present some of the recent data on this gene family with reference to selected phenotypes observed in patients and model organisms, and the sensitivity of developmental processes to alterations in forkhead gene dosage.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 14
Typ av publikation
Typ av innehåll
refereegranskat (13)
övrigt vetenskapligt/konstnärligt (1)
Författare/redaktör
Holzmann, Martin J. (2)
Carlsson, Axel C. (2)
Svardsudd, K (1)
Norlen, BJ (1)
Gustafson, R. (1)
Willander, Magnus (1)
visa fler...
Jager, Edwin (1)
Johansson, Christer (1)
Wennerberg, Ann, 195 ... (1)
Larsson, P (1)
Adami, HO (1)
Adolfsson, J. (1)
Bölte, Sven (1)
Abrahamsson, PA (1)
Nur, Omer, 1959- (1)
Johansson, JE (1)
Pontén, J. (1)
Lundkvist, Åke (1)
Carlsson, P (1)
Marké, LA (1)
Svensson, P (1)
Jonsson, E (1)
Gustavsson, O (1)
Taylor, Mark J. (1)
Nilner, Krister (1)
Molin, M (1)
Carlsson, Peter, 195 ... (1)
Nyman, CR (1)
Norming, U (1)
Rusu, Cristina (1)
Holm, B. (1)
Wahab, Qamar Ul (1)
Berge, Maria, 1979- (1)
Hollander, Monika (1)
Pettersson, S (1)
Al-Hilli, Safaa, 196 ... (1)
Tedroff, J (1)
Jonsson, Ulf, 1974- (1)
Persson, Katrin (1)
Verner-Carlsson, Jen ... (1)
Carlsson, Jens (1)
Trulsson, M (1)
Carlsson, Sigrid, 19 ... (1)
Routti, Heli (1)
Dietz, Rune (1)
Damber, JE (1)
Carlsson, J (1)
van der Wijngaart, W ... (1)
Tennvall, Jan (1)
Muller, F (1)
visa färre...
Lärosäte
Göteborgs universitet (6)
Uppsala universitet (5)
Karolinska Institutet (5)
Umeå universitet (1)
Kungliga Tekniska Högskolan (1)
Stockholms universitet (1)
visa fler...
Linköpings universitet (1)
Lunds universitet (1)
Malmö universitet (1)
Chalmers tekniska högskola (1)
visa färre...
Språk
Engelska (14)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (10)
Naturvetenskap (2)
Teknik (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy